435
Views
11
CrossRef citations to date
0
Altmetric
Letters

Ustekinumab as adjuvant treatment for all pyoderma gangrenosum subtypes

ORCID Icon, , , &
Pages 2386-2390 | Received 05 May 2021, Accepted 25 May 2021, Published online: 14 Jun 2021
 

Disclosure statement

Dr. Ortega-Loayza has participated in Advisory Boards for Janssen and Bristol Mayer Squibb. Authors declare that the contents of this article are their own original unpublished findings.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access
  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart
* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.